Ticker Details
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.
IPO Date:	June 25, 2014
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$946.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 1.68%
Avg Daily Range (30 D):	$0.43 | 2.04%
Avg Daily Range (90 D):	$0.45 | 1.81%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	41

Institutional Trades
Total Institutional Trades:	2,549
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.86M
Avg Institutional Trade (90 D):	$1.63M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.05M
Avg Closing Trade (30 D):	$2.02M
Avg Closing Trade (90 D):	$1.73M
Avg Closing Volume:	69.24K

News

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Jun 5, 2025 @ 5:00 PM Global Antidote Market to Cross the USD 4 Billion ... Source: Delveinsight

Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh

Jul 23, 2024 @ 5:01 PM HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202... Source: N/A

May 30, 2024 @ 6:06 AM Amphastar Pharmaceuticals: Buy When Fear Is Overbl... Source: James Long

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.1	$.53	$2.1
Diluted EPS	$2.03	$.51	$2.03
Revenue	$719.89M	$183.11M	$719.89M
Gross Profit	$356.06M	$85.67M	$356.06M
Net Income / Loss	$98.09M	$24.43M	$98.09M
Operating Income / Loss	$140.4M	$35.61M	$140.4M
Cost of Revenue	$363.83M	$97.44M	$363.83M
Net Cash Flow	$18.57M	$-46.09M	$18.57M
PE Ratio	10.03